Eur Heart J:工作场所欺凌和暴力是心血管疾病的危险因素

2018-11-19 xing.T MedSci原创

由此可见,欺凌和暴力在工作场所较为常见,那些暴露于这些应激源的个体患CVD的风险更高。

近日,血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员旨在评估欺凌和工作暴力与血管疾病(CVD)之间的关系。

该研究的参与者为79201名职场男性和女性,年龄为18-65岁,无CVD,来自瑞典和丹麦的三项队列研究。在基线时研究人员使用自我报告测量了暴露于工作场所的欺凌和暴力情况。参与者与全国健康和死亡登记中心相关联,以确定CVD事件,包括冠心病和脑血管疾病。通过边缘结构Cox回归估计研究特异性结果,并使用固定效应荟萃分析进行组合。

9%的受访者表示在工作中受到欺凌,13%的受访者表示在过去的一年中遭遇过工作场所的暴力。研究人员记录了3229例CVD事件,平均随访12.4年(前4年为765例)。在调整年龄、性别、出生国家、婚姻状况和教育水平后,在工作中被欺凌与未受欺凌的参与者相比CVD的风险比(HR)为1.59 [95%置信区间(CI)为1.28-1.98]。经历工作场所暴力与未经厉暴力相比CVD的HR为1.25(95%CI为1.12-1.40)。工作场所欺凌的人口归因风险为5.0%,工作场所暴力为3.1%。在不同的随访时间,心血管危险分层以及经过额外调整后的分析中,超额风险仍然相似。研究人员观察到工作场所欺凌和暴力与CVD之间的剂量-反应关系(趋势P<0.001)。在研究特定的估计中,异质性几乎可以忽略不计。

由此可见,欺凌和暴力在工作场所较为常见,那些暴露于这些应激源的个体患CVD的风险更高。

原始出处:

Tianwei Xu.et al.Workplace bullying and workplace violence as risk factors for cardiovascular disease: a multi-cohort study. Eur Heart J.2018.https://doi.org/10.1093/eurheartj/ehy683

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
    2018-11-21 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
    2018-11-21 slcumt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
    2018-11-21 15938038573红旗飘飘

    已学习并已分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1946763, encodeId=fd151946e630a, content=<a href='/topic/show?id=631d4e87628' target=_blank style='color:#2F92EE;'>#工作场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47876, encryptionId=631d4e87628, topicName=工作场所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Oct 26 00:30:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357004, encodeId=1da5135e00462, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498496, encodeId=995114984964f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563006, encodeId=75a31563006ec, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584203, encodeId=1337158420317, content=<a href='/topic/show?id=0ba6631292b' target=_blank style='color:#2F92EE;'>#欺凌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63129, encryptionId=0ba6631292b, topicName=欺凌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3217016796, createdName=ms9203727104890838, createdTime=Wed Nov 21 10:30:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353212, encodeId=9f97353212d1, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Wed Nov 21 06:46:41 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353084, encodeId=6a9135308485, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Nov 19 20:27:36 CST 2018, time=2018-11-19, status=1, ipAttribution=)]
    2018-11-19 医者仁心5538

    学习了

    0

相关资讯

JOEH:隐性成本揭露:工作场所日光照射引起的皮肤癌

由于工作原因经常暴露在阳光下而造成的皮肤癌,每年都需要花费数百万美元。因此研究者希望政策制定者能妥善处理这一问题。

带你参观历史上10位科学天才们工作的地方

据说爱因斯坦曾经说过这样的话:"如果桌子凌乱是大脑凌乱的象征,那么空荡荡的桌子又意味着什么呢?"也许这仅仅是一句俏皮话,可能是爱因斯坦在被评价说不会整理桌子时做出的回应。但事实上我们整理工作室的方式的确能够反映很多问题。过去的研究已经发现工资高的人都不太爱整理桌子。2013年来自明尼苏达大学的科学家们发现桌子混乱标志着创造力与探索精神,而桌子整洁则表明恪守常规,不太爱冒风险。当然,这方面的研究

[ESC2012] 工作场所健身更有效预防疾病

  一项德国研究者进行的工作健身计划的初期数据提示,如果在工作场所而不是在医生诊所进行干预,预防策略可能会更有效。该计划始于2005年,最终减少了吸烟、改善了血压控制、降低了代谢综合征发病率,并改善了10年预期的心血管疾病危险。该研究结果在欧洲心脏病学会2012年会上报告。   研究者指出,工作场所更适于进行一级和二级预防,更年轻的患者,包括未测出高血压和胆固醇水平升高者,并不经常接受医生的一级

心理卫生学术大会调查显示:70%受访者因抑郁症请假中断工作

中国首次发布工作场所中的抑郁症调查数据,核心信息以下: 1.调查发现,70%的抑郁症患者因为抑郁症而请假中断工作,超过一半的抑郁症患者认为注意力集中困难而使工作效率低于平常水平导致休病假; 2.53%的管理者呼吁政府要更好的立法和制定政策保护抑郁患者。 中国北京 2014年8月15日,第七届心理卫生学术大会在京召开,中国心理卫生协会副理事长兼秘书长,首都医科大学附属北京安定医